# Biostatistics Core

> **NIH NIH P01** · DANA-FARBER CANCER INST · 2020 · $133,238

## Abstract

Project Summary/Abstract
The purpose of Core C Biostatistics is to provide statistical support to all the Projects in this P01. For the
association of clinical outcome with novel findings of putative genetic or methylation drivers, or new clusters of
samples reflecting gene pathways or networks, in Project 1, the Core will assemble and curate the clinical
data provided by internal and external collaborators, and perform all analyses of association between these
novel findings and appropriate clinical parameters. For all laboratory and animal studies of Projects 2 and 3,
this includes assurance that the design, conduct, and analysis of experiments using robust statistical
techniques that are appropriately implemented. For DBP studies performed through Project 3, the Core will
permit Project 3 to remain blinded to clinical outcomes when performing their assays, and will assess the
predictive ability of the assay on behalf of Project 3. Through these aims, this central resource for the Projects
will coordinate intra-lab interactions to meet the goal of identifying novel aspects of the CLL genome and
phenome and their associations with patient outcome.

## Key facts

- **NIH application ID:** 10005156
- **Project number:** 5P01CA206978-05
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** DONNA S. NEUBERG
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $133,238
- **Award type:** 5
- **Project period:** 2016-09-01 → 2021-09-16

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10005156

## Citation

> US National Institutes of Health, RePORTER application 10005156, Biostatistics Core (5P01CA206978-05). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10005156. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*